Pfizer
PFE
3,160 hedge funds and large institutions have $202B invested in Pfizer in 2022 Q2 according to their latest regulatory filings, with 131 funds opening new positions, 1,404 increasing their positions, 1,263 reducing their positions, and 120 closing their positions.
52% more funds holding in top 10
Funds holding in top 10: 166 → 252 (+86)
11% more repeat investments, than reductions
Existing positions increased: 1,404 | Existing positions reduced: 1,263
1.57% more ownership
Funds ownership: 67.21% → 68.78% (+1.6%)
9% more first-time investments, than exits
New positions opened: 131 | Existing positions closed: 120
3% more capital invested
Capital invested by funds: $197B → $202B (+$5.6B)
1% more call options, than puts
Call options by funds: $2.83B | Put options by funds: $2.81B
1% less funds holding
Funds holding: 3,195 → 3,160 (-35)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital World Investors
Los Angeles,
California
|
+$1.54B |
| 2 |
BlackRock
New York
|
+$1.38B |
| 3 |
Morgan Stanley
New York
|
+$1.28B |
| 4 |
Capital International Investors
Los Angeles,
California
|
+$556M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$478M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
D.E. Shaw & Co
New York
|
-$355M |
| 2 |
Renaissance Technologies
New York
|
-$311M |
| 3 |
Franklin Resources
San Mateo,
California
|
-$295M |
| 4 |
Barclays
London,
United Kingdom
|
-$210M |
| 5 |
1832 Asset Management
Toronto,
Ontario, Canada
|
-$193M |
PFE Hedge Fund Activity: Q2 2022 in Review
3,160 of the 5,959 institutional investors tracked by Wall St. Rank reported a position in Pfizer (PFE) for Q2 2022, worth a combined $202B — up 2.8% from $197B a quarter earlier.
Buyers outnumbered sellers: 131 funds opened new PFE positions and 120 closed out — a net gain of 11 holders — while 1,404 added to existing stakes and 1,263 trimmed.
The largest buyer was Capital World Investors, adding an estimated $1.54B. The largest seller was D.E. Shaw & Co, cutting an estimated $355M.
- 3,160 institutional investors held Pfizer (PFE) as of Q2 2022, down from 3,195 in Q1 2022.
- Funds reported $202B of Pfizer stock for Q2 2022, up 2.8% quarter-over-quarter.
- 131 funds opened new Pfizer positions in Q2 2022 and 120 closed out, a net change of +11 holders.
- The largest Pfizer buyer in Q2 2022 was Capital World Investors, an estimated $1.54B added.
- The largest Pfizer seller in Q2 2022 was D.E. Shaw & Co, an estimated $355M sold.
Based on aggregated 13F filings for Q2 2022.